Delivery Order SPE2DB22D2007-SPE2DB25FJ2QR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,095.09 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials, with an ultimate completion date of July 21, 2025. This non-set-aside contract employs firm fixed pricing and represents a discrete purchase order under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,095.09 delivery order to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/ml vials, with an ultimate completion date of July 22, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a child order under AmerisourceBergen's larger federal contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Phenobarbital 65 mg/mL vials. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,018.74 and is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this requirement from its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $2,019.16 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials. This non-set-aside, competitively awarded contract employs firm fixed pricing and was executed on April 24, 2025, with an ultimate completion date of April 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,562.39 to AmerisourceBergen Drug Corp for Phenobarbital 130 mg/mL vials, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor on this...
- The Defense Logistics Agency awarded a delivery order valued at $1,270.51 to AmerisourceBergen Drug Corp for Phenobarbital 65 mg/mL vials, with an ultimate completion date of September 22, 2025. This is a firm fixed-price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order valued at $4,494.60 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 65 mg/ml vials, with an ultimate completion date of April 8, 2025. This firm fixed price delivery order, awarded on April 7, 2025, was competitively awarded with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,285.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Phenobarbital 130 mg/ml vials. The contract represents a non-set-aside competitive award with an ultimate completion date of August 29, 2025, and performance location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Phenobarbital 65 mg/ml vials, with a ceiling value of $4,516.61 and an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Phenobarbital 130 mg/mL vials valued at $3,106.84. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 5, 2025, with the place of performance located in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical vendor for federal medical procurement, specifically supporting...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ2QRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,789.75 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials. This firm fixed-price, competitively awarded contract contains no set-aside designation and is scheduled for completion by July 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply chain requirements. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs worldwide. Through this flexible contract structure, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the company demonstrating substantial capability in fulfilling federal medical procurement needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 6/30/25 |